JUNIPER GROUP INC
10QSB, 1998-05-15
INSURANCE AGENTS, BROKERS & SERVICE
Previous: LUNAR CORP, 10-Q, 1998-05-15
Next: FIRST PALMETTO FINANCIAL CORP, 10-Q, 1998-05-15





                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   Form 10-QSB





QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 
OF 1934

                             For the quarterly period ended March 31, 1998
                             ---------------------------------------------

                             Commission file number    0-19170


                              JUNIPER GROUP, INC.
 -------------------------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)


      New York                                               11-2866771
- -------------------------------------------------------------------------------
 (State or other jurisdiction of               (IRS Employer Identification No.)
 incorporation or organization)

           111 Great Neck Road, Suite 604, Great Neck, New York 11021
- --------------------------------------------------------------------------------
                    (Address of principal executive offices)


                                 (516) 829-4670
- --------------------------------------------------------------------------------
                           (Issuer's telephone number)



- --------------------------------------------------------------------------------
              (Former name, former address and former fiscal year,
                          if changed since last report)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days.   Yes  X      No
                                                                ---        ---




     The number of shares  outstanding of each of the issuer's classes of common
equity, as of the latest practicable date, May 6, 1998, was 51,979,513 shares of
common stock - $.001 par value.



Transitional Small Business Disclosure Format:  Yes       No  X
                                                   ---       ---


                                       1
<PAGE>
        
PART I - FINANCIAL INFORMATION

ITEM 1:   Financial Statements



                             JUNIPER GROUP, INC.
                            AND SUBSIDIARY COMPANIES

                           CONSOLIDATED BALANCE SHEETS

                                                        March        December
        Assets                                         31, 1998      31, 1997
                                                     -----------    -----------
Current Assets
  Cash ...........................................   $   185,912    $    30,187
  Accounts receivable - trade ....................       403,173        363,480
  Due from affiliates ............................        11,466         15,570
  Prepaid expenses and other current assets ......       149,014        141,098
  Due from officer ...............................       121,000           -   
                                                     -----------    -----------
      Total current assets .......................       870,565        550,335
  Film licenses ..................................     2,954,562      2,954,562
  Property and equipment net of accumulated
    depreciation of $73,526 and $127,382
    respectively .................................        62,476         98,911
  Other assets ...................................           183          2,049
                                                     -----------    -----------
                                                     $ 3,887,786   $  3,605,857
                                                     ===========    ===========

       LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
  Accounts payable and accrued expenses ..........   $   796,957   $    835,427

  Notes payable - current ........................       562,075        342,571
  Due to producers - current .....................        62,086         62,086
  Due to officer .................................          -            68,662
  Due to shareholders ............................         7,000          7,000
                                                     -----------    -----------
       Total current liabilities .................     1,428,118      1,315,746 
Due to producers - long term .....................        87,406         93,814
                                                     -----------    -----------
       Total liabilities .........................     1,515,524      1,409,560
                                                     -----------    -----------

Shareholders' Equity
  12% Non-voting convertible redeemable
   preferred stock: $.10 par value, 875,000
   shares authorized, 235,900 shares issued
   and outstanding at March 31, 1998, and
   December 31, 1997: aggregate liquidation
   preference, $471,800 at March 31, 1998
   and December 31, 1997 .........................        23,590         23,590
  Common Stock - $.001 par value, 300,000,000
   shares authorized, 51,121,139 and 37,995,083
   issued and outstanding at March 31, 1998
   and December 31, 1997 respectively  ...........        51,121         37,995
  Capital contributions in excess of par:
   Attributed to preferred stock .................       210,303        210,303
   Attributed to common stock ....................     8,331,186      7,934,744
  Retained earnings (deficit) ....................    (6,243,938)    (6,010,335)
                                                     -----------    -----------
   Total shareholders' equity ....................     2,372,262      2,196,297
                                                     -----------    -----------
                                                     $ 3,887,786    $ 3,605,857
                                                     ===========    ===========

                 See Notes to Consolidated Financial Statements

                                      2
<PAGE>



                             JUNIPER GROUP, INC.
                            AND SUBSIDIARY COMPANIES

                        CONSOLIDATED STATEMENTS OF INCOME





                                                      Three Months Ended
                                                   March 31,         March 31,
                                                     1998              1997
                                                ------------       ------------
Revenues:
     Healthcare ..............................  $    208,435       $    496,089
     Entertainment ...........................         -                   -
                                                ------------       ------------
                                                     208,435            496,089
                                                ------------       ------------

Operating Costs:
     Healthcare ..............................        21,775            176,964
     Entertainment ...........................         -                   -   
Selling, general and administrative expenses .       420,263            418,305
                                                ------------       ------------
                                                     442,038            595,269
                                                ------------       ------------

Net income (loss) ............................  $   (233,603)      $    (99,180)
                                                ============       ============

Weighted average number of shares outstanding     47,385,792         19,027,516
                                                ============       ============
Net income (loss) per common share              $      (0.01)      $      (0.01)
                                                ============       ============































                 See Notes to Consolidated Financial Statements


                                       3
<PAGE>



                             JUNIPER GROUP, INC.
                            AND SUBSIDIARY COMPANIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS


                                                       Three Months Ended
                                                   March 31,         March 31,
                                                     1998              1997
                                                 ------------      ------------
Operating Activities
Net income (loss) ............................   $(233,603)           $ (99,180)
Adjustments to reconcile net cash provided
  by operating activities:
 Amortization expense.........................        --                     88
 Depreciation expense ........................      10,211               10,416
 Gain on disposition of assets ...............      (6,362)                --
 Payment of officer's compensation with equity     209,724                8,592
 Payment of various liabilities with equity ..       3,950               35,840
 Payment of employees compensation with equity        --                 16,250
Changes in assets and liabilities:
 Accounts receivable .........................     (39,693)             (17,802)
 Prepaid expenses and other current assets ...      (7,916)             (25,666)
 Due to/from officers ........................    (189,662)             (10,932)
 Due from affiliates .........................       4,104                  490 
 Accounts payable and accrued expenses .......     (38,470)              55,007 
                                                 ---------            ---------
 Net cash provided from (used for)
   operating activities ......................    (287,717)             (26,897)
                                                 ---------            ---------

Investing activities:
 Sale (purchase) of equipment ................      (5,250)               --
                                                  ---------           ---------
                 
Financing activities:
 Reduction in borrowings .....................     (90,794)             (37,046)
 Proceeds from borrowings ....................     400,000               75,000
 Payments to and on behalf of producers ......      (6,408)             (25,398)
 Proceeds from private placements ............     145,894                --   
                                                 ---------            ---------
 Net cash provided from (used for)
   financing activities ......................     448,692               12,556
                                                 ---------            ---------
 Net increase (decrease in cash) .............     155,725              (14,341)
 Cash at beginning of period .................      30,187               14,593
                                                 ---------            ---------
 Cash at end of period .......................   $ 185,912            $     252
                                                 =========            =========


Supplemental cash flow information:
  Interest paid ..............................   $   6,340            $   1,082
                                                 ---------            ---------










                 See Notes to Consolidated Financial Statements

                                       4
<PAGE>

                              JUNIPER GROUP, INC.

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
                                   (Unaudited)

NOTE 1 - Basis of Presentation:

     The interim  consolidated  financial  statements  included herein have been
prepared without audit,  pursuant to the rules and regulations of the Securities
and Exchange Commission ("SEC").  Certain information and footnote  disclosures,
normally  included  in the  financial  statements  prepared in  accordance  with
generally  accepted  accounting  principles,  have  been  condensed  or  omitted
pursuant to SEC rules and regulations;  nevertheless,  management of the Company
believes  that the  disclosures  herein  are  adequate  to make the  information
presented not misleading. The consolidated financial statements and notes should
be read in conjunction with the audited  consolidated  financial  statements and
notes  thereto as of December 31, 1997  included in the  Company's  Form 10-KSB
filed with SEC.

     In the opinion of management,  all  adjustments  consisting  only of normal
recurring  adjustments  necessary to present fairly the  consolidated  financial
position  of the Company  with  respect to the  interim  consolidated  financial
statements have been made. The results of operations for the interim periods are
not necessarily indicative of the results to be expected for the full year.








































                                        5
<PAGE>
Item 2  MANAGEMENT'S  DISCUSSION  AND ANALYSIS OR PLAN OF OPERATION

     The following discussion and analysis of financial condition and results of
operations  should  be read  in  conjunction  with  the  Company's  consolidated
financial statements and notes thereto included elsewhere herein. The statements
disclosed  herein  include  forward-looking  statements  within  the  meaning of
Section  27A of the  Securities  Act of 1933,  as amended and Section 21E of the
Securities Exchange Act of 1934, as amended.  The Company's actual results could
differ  materially from those projected in the  forward-looking  statements as a
result of certain risks and  uncertainties,  including,  but not limited to, the
Company's  historical lack of  profitability,  the Company's need for additional
financing,  competition  in the managed  health care  industry,  and other risks
detailed  from time to time in the  Company's  filings with the  Securities  and
Exchange Commission.

OVERVIEW  
- --------

     Juniper Group, Inc. (the "Company")is a Nevada  Corporation.  Its principal
businesses are composed of two segments,  healthcare and entertainment:  (i) the
healthcare  operations are conducted through two subsidiaries of Juniper Medical
Systems,  Inc. ("JMSI"),  which is a wholly owned subsidiary of the Company: (a)
PartnerCare,  Inc. ("PCI"), a managed care revenue enhancement company providing
various types of services such as: Physician Practice  Management,  Managed Care
Revenue  Enhancement,   Comprehensive   Pricing  Reviews,   MSOs  and  Liability
Assessment  Programs to newly evolving integrated hospital and physician markets
and (b) Juniper Healthcare  Containment  Systems,  Inc.  ("Containment"),  which
develops and provides full service healthcare  networks for insurance  companies
and managed  care  markets in the  Northeast  U.S.;  and (ii) the  entertainment
segment is conducted principally through Juniper Pictures, Inc. ("Pictures"),  a
wholly owned subsidiary of Juniper  Entertainment,  Inc. ("JEI"), a wholly owned
subsidiary of the Company,  which engages in the  acquisition,  exploitation and
distribution of rights to films to the various media (i.e., home video,  pay-per
view, pay television,  cable  television,  networks and  independent  syndicated
television  stations)  in the domestic and foreign  marketplace.  The  Company's
operations  are based at 111 Great Neck Road,  Suite 604,  Great Neck,  New York
11021.

RESULTS OF OPERATIONS
- ---------------------

Three  Months  Ended  March 31, 1998 vs Three  Months  Ended March 31, 1997
- ---------------------------------------------------------------------------
     
     Revenue  related to the  Healthcare  segment  decreased  to $208,000 in the
first quarter of 1998 from $496,000 in the first quarter of 1997, representing a
58%  decrease.  The  decrease  in revenue  during the first  quarter of 1998 was
predominately  attributed  to  Containment,  which had revenue of  approximately
$108,000 in the first quarter of 1998, compared to approximately $284,000 in the
first quarter of 1997, a 62% decrease. This is a result of changes instituted in
December 1997, whereby Containment  discontinued a joint venture arrangement and
its arrangement with the Guardian Insurance  Company.  The loss of this business
has been  temporarily  replaced with a settlement  agreement which will generate
revenue with no corresponding  expense  throughout 1998. PCI's revenue decreased
to $100,000 in 1998,  from $212,000 in 1997. This was the result of PCI's change
in direction  from a DRG audit  company to a Managed  Care  Revenue  Enhancement
company.

     The  entertainment  segment  recognized  no revenue in the first quarter of
1998,  or the  first  quarter  of 1997.  Certain  of the  Company's  films  that
generated  revenue when the contracts were signed are still under  license,  and
are currently being aired by the licensees.  The Company is currently  utilizing
its  resources  to build the  healthcare  segment of its  business,  and has not
devoted  resources  toward the promotion and  solicitation of the films in 1997.
However,  the Company has begun looking for outside  salesmen to help market and
marchandise the films that are not currently under license.

     Healthcare  operating  costs  decreased to $22,000 in the first  quarter of
1998 from $177,000 in the first quarter of 1997, a 88% decrease. As a percentage
of revenue, operating costs of the healthcare operations decreased to 11% in the
first quarter of 1998 from 36% in the first quarter of 1997. The decrease is due
to the fact that operating costs for  Containment  were lower because of the new
Joint Venture.
 
     Selling,  general and administrative  expenses increased to $420,000 in the
first quarter of 1998 from $418,000 in the first quarter of 1997, a 1% increase.
This increase is primarily  due to increases in bad debt expense of  $70,000(due
to a more  conservative  evaluation of the Company's  accounts  receivable)  and
public relations  expense of $31,000,  offset by a reduction of employee medical
benefits of $28,000,  costs associated with the 1997 annual meeting and issuance
of proxy statements of $30,000, office related expenses of $16,000, salaries and
related taxes of $13,000 and  information  system  expenses of $12,000.  Most of
these  decreases were related to the  management  changes in PCI during 1997 and
the corresponding redirection of time and resources of management initiatives to
re-engineer  and  diversify  product lines  through the  development  of the new
information systems.

                                       6
<PAGE>

 

LIQUIDITY AND CAPITAL RESOURCES
- -------------------------------

     Working  capital  deficiency  at March 31, 1998 was  $558,000,  compared to
working  capital  deficiency  of  $765,000 at December  31,  1997.  The ratio of
current assets to current  liabilities  was .61:1 at March 31, 1998 and .42.1 at
December 31, 1997. Cash flow used in operations during the first quarter of 1998
was $288,000,  compared to cash flow used in operations during the first quarter
of 1997, of $27,000.

     Accounts receivable - trade increased to $403,000 from $363,000 at December
31, 1997.

     Accounts  payable  decreased to $797,000  from $835,000 at December 31,
1997.

     Although the Company plans to continue to expand its healthcare business to
the extent that  resources  are  available,  the  Company  has no firm  material
commitments  for capital  expenditures in other areas of its business and has no
plans to acquire additional films.

     The Company believes that it may not have sufficient  liquidity to meet its
operating  cash  requirements  for the current  level of  operations  during the
remainder of 1998. The Company will require additional  financing.  There can be
no  assurance  that  financing  will be  available,  or if  available, on  terms
acceptable to the Company.  If the Company is unable to fund its operating  cash
flow needs, the Company may be required to substantially curtail operations.

     The Company currently does not have any bank lines of credit.

     At  the  Company's  annual  meeting,  management  eliminated  shareholders'
pre-emptive rights, which previously existed under New York law. Notwithstanding
these rights,  the Company has on a number of occasions  issued  shares  without
affording  shareholders  the  opportunity  to  exercise  pre-emptive  rights and
without  procuring waivers of such rights. No shareholder has alleged any damage
resulting  to him as a  result  of the sale of  shares  by the  Company  without
offering  pre-emptive  rights. The amount of damages incurred by shareholders by
reason of the failure of the Company to offer pre-emptive rights, if any, is not
ascertainable  with any degree of accuracy.  Management  believes that if claims
were asserted alleging damages, the Company may have valid defenses.
















                                       7

<PAGE>

PART II:   OTHER INFORMATION

Item  2.  Changes  in  Securities
          -----------------------

(a)  The  information  disclosed  in  Item 4 below  is  incorporated  herein  by
     reference.

(b)  N/A

(c)  Common Stock,  $0.001 par value,  sold in the first quarter of 1998 were as
     follows:

<TABLE>
<CAPTION>

       Date              Purchaser          Amount (#)         Amt. Paid ($)       Description         Exemption
- -------------------- ------------------ ------------------- ------------------  ------------------- -----------------
<S>  <C>               <C>                 <C>                  <C>                    <C>              <C>
     3/31/98           Officers            6,990,802            209,724                (1)               4(2)
     3/31/98           Vendors               56,461              3,950                 (2)               4(2)
     3/31/98            Reg S              6,078,793            195,894                (3)              Reg. S

</TABLE>

_______________________

(1)  The  President  and CEO of the  Company  accepted  common  stock in lieu of
     accrued salary.

(2)  Vendors accepted common stock in lieu of unpaid fees.

(3)  A non-U.S. consultant  accepted common stock in lieu of  consulting  fees
     relating to public relations services provided to the Company.


Item 3.  Defaults Upon Senior Securities
         -------------------------------
     Preferred  Stockholders  are  entitled  to  receive  out of assets  legally
available  for  payment a dividend  at a rate of 12% per annum of the  Preferred
Stock  liquidation  preference  of $2.00 (or $.24 per annum) per share,  payable
quarterly  on March 1, June 1,  September 1 and December 1, in cash or in shares
of Common Stock having an equivalent fair market value.  Unpaid dividends on the
Company's  Preferred Stock cumulate.  The quarterly  payments due on September 1
and December 1, 1992,  and all payments due in 1993,  in 1994,  in 1995  and in
1997  and the  payment  due on  March 1,  1998  have not yet been  paid and are
accumulating.  These dividends have not been declared  because earned surplus is
not available to pay a cash dividend.  Accordingly,  dividends  will  accumulate
until such time as earned surplus is available to pay a cash dividend or until a
post  effective  amendment to the Company's  registration  statement  covering a
certain  number of common  shares  reserved for the payment of  Preferred  Stock
dividends is filed and declared  effective,  or if such number of common  shares
are  insufficient  to pay cumulative  dividends,  then until  additional  common
shares are  registered  with the Securities and Exchange  Commission  (SEC).  No
dividends  shall be declared or paid on the Common  Stock (other than a dividend
payable  solely  in  shares  of  Common  Stock)  and no  Common  Stock  shall be
purchased,  redeemed or acquired by the Company unless full cumulative dividends
on the Preferred  Stock have been paid or declared,  or cash or shares of Common
Stock have been set apart which is sufficient  to pay all  dividends  accrued on
the Preferred Stock for all past and then current dividend periods.

     As stated above,  pursuant to the terms of the Preferred Stock, the Company
has the option of making quarterly dividend payments in cash or shares of Common
Stock. The Company does not intend to make any Preferred Stock dividends in cash
in the foreseeable future.  Prospectively,  subject to the Company's  Prospectus
being current,  and a sufficient  number of common shares being  registered with
the SEC, the Company anticipates making quarterly dividend payments in shares of
Common Stock for the  foreseeable  future  including the payments which have not
yet been made.  The total cash value of the  arrearage  of unpaid  dividends  is
$326,000.



                                       8


<PAGE>

Item 6.  Exhibits and Reports on Form 8-K
         --------------------------------
 (a) Exhibits

Exhibit                  Description 

 3.1  Certificate of Incorporation of the Registrant, as amended (1)

 3.2  Amendment to the Certificate of Incorporation of the Registrant, filed
      March 7, 1998 (2)

 3.3  Certificate of Incorporation of Juniper Group, Inc., a Nevada
      corporation.(3)

 3.4  By-Laws of the Registrant (1)

 3.5  Amendment to the By-Laws of the Registrant approved by the shareholders
      of the Registrant on February 12, 1998 (3)

 3.6  By-Laws of Juniper Group, Inc., a Nevada corporation (3)

27.1  Financial Data Schedule
- ----  -----------------------

     (1) Incorporated by reference to the Company's Annual Report on Form 10-KSB
     for the fiscal year ended December 31, 1995

     (2) Incorporated by reference to the Company's Annual Report on Form 10-KSB
     for the fiscal year ended December 31, 1997

     (3)  Incorporated by reference to the Company's Proxy  Statement for its
     Annual Meeting held in February 1998


(b)      Reports on Form 8-K.

         NONE



























                                       9

<PAGE>





                                   SIGNATURES



     In accordance  with the  requirements  of the Exchange Act, the  Registrant
caused this report to be signed by the undersigned, thereunto duly authorized.



                                        JUNIPER GROUP, INC.



Date: May 14, 1998



                                        By:/s/ Vlado P. Hreljanovic
                                           ------------------------
                                            Vlado P. Hreljanovic
                                            Chairman of the Board, President,
                                            Chief Executive Officer and Acting
                                            Chief Financial Officer
 







































                                       10
<PAGE>


                                EXHIBIT INDEX


Exhibit                            Description


27.1  Financial Data Schedule




<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE  CONTAINS SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF INCOME FOUND ON PAGES
3 & 4 OF THE COMPANY'S FORM 10-QSB FOR THE THREE MONTHS ENDED MARCH 31, 1998.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-mos
<FISCAL-YEAR-END>                              DEC-31-1998
<PERIOD-START>                                 JAN-01-1998
<PERIOD-END>                                   Mar-31-1998
<CASH>                                         185,912
<SECURITIES>                                   0
<RECEIVABLES>                                  403,173
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               870,565
<PP&E>                                         136,002
<DEPRECIATION>                                 73,526
<TOTAL-ASSETS>                                 3,887,786
<CURRENT-LIABILITIES>                          1,428,118
<BONDS>                                        0
                          0
                                    23,590
<COMMON>                                       51,121
<OTHER-SE>                                     2,297,551
<TOTAL-LIABILITY-AND-EQUITY>                   3,887,786
<SALES>                                        0
<TOTAL-REVENUES>                               208,435
<CGS>                                          0
<TOTAL-COSTS>                                  442,038
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                (233,603)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (233,603)
<EPS-PRIMARY>                                  (0.01)
<EPS-DILUTED>                                  (0.01)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission